# Citrullus mucosospermus Extract Exerts Protective Effects against Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis in Mice

**Authors:** Sun Young Park, Ji Eun Kim, He Mi Kang, Ki Ho Park, Byoung Il Je, Ki Won Lee, Dae Youn Hwang, Young Whan Choi

PMC · DOI: 10.3390/foods13132101 · Foods · 2024-07-01

## TL;DR

Citrullus mucosospermus extract helps protect mice from liver damage caused by a diet linked to nonalcoholic steatohepatitis.

## Contribution

CME shows protective effects against NASH in mice by reducing inflammation and oxidative stress without altering serum lipids.

## Key findings

- CME reduced liver damage markers and enzyme levels like ALT and AST in mice.
- CME modulated NASH-related genes and restored key lipase activities for fat breakdown.
- CME mitigated oxidative stress by enhancing Nrf2 and SOD activity.

## Abstract

In recent years, there has been increasing interest in exploring the potential therapeutic advantages of Citrullus mucosospermus extracts (CME) for nonalcoholic steatohepatitis (NASH). In this study, we investigated the therapeutic effects of CME on NASH using a mice model. High-performance liquid chromatography (HPLC) was employed to identify cucurbitacin E and cucurbitacin E-2-O-glucoside from the CME. Although CME did not significantly alter the serum lipid levels in methionine- and choline-deficient (MCD) mice, it demonstrated a protective effect against MCD diet-induced liver damage. CME reduced histological markers, reduced alanine transaminase (ALT) and aspartame transaminase (AST) levels, and modulated key NASH-related genes, including C/EBPα, PPARγ, Fas, and aP2. In addition, CME was found to restore hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) activity, both crucial for fat catabolism, and reduced the levels of pro-inflammatory cytokines. Furthermore, CME demonstrated the potential to mitigate oxidative stress by maintaining or enhancing the activation and expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and superoxide dismutase (SOD), both pivotal players in antioxidant defense mechanisms. These findings underscore the promising therapeutic potential of CME in ameliorating liver damage, inflammation, and oxidative stress associated with NASH.

## Linked entities

- **Genes:** CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], FAS (Fas cell surface death receptor) [NCBI Gene 355], FABP4 (fatty acid binding protein 4) [NCBI Gene 2167], LIPE (lipase E, hormone sensitive type) [NCBI Gene 3991], PNPLA2 (patatin like domain 2, triacylglycerol lipase) [NCBI Gene 57104], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], SOD1 (superoxide dismutase 1) [NCBI Gene 6647]
- **Chemicals:** cucurbitacin E (PubChem CID 5281319), cucurbitacin E-2-O-glucoside (PubChem CID 5459275), methionine (PubChem CID 876), choline (PubChem CID 305)
- **Diseases:** nonalcoholic steatohepatitis (MONDO:0007027), NASH (MONDO:0007027)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** inflammation (MESH:D007249), liver damage (MESH:D056486), NASH (MESH:D065626)
- **Chemicals:** cucurbitacin E (MESH:C102326), lipid (MESH:D008055), Choline (MESH:D002794), CME (-), Methionine (MESH:D008715)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11240977/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11240977/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC11240977/full.md

---
Source: https://tomesphere.com/paper/PMC11240977